Vol 2005, No 64 (2005)

Table of Contents

Deal Trackers

Increlex (mecasermin) Abstract pdf
Business Review Editor

Research & Development

Cyto Pulse Collaborates with US Army Abstract pdf
Business Review Editor
Astex Continues to Sign with Big Pharma Abstract pdf
Business Review Editor

Features

GSK Keeps an Eye on Vaccines Business with Potential ID Biomedical Acquisition Abstract pdf
Business Review Editor
EpiCept Merges with Maxim to Go Public Abstract pdf
Business Review Editor
When and How to Find the Right Partner Abstract pdf
Business Review Editor
Therapy Focus: Schizophrenia Abstract pdf
Business Review Editor

Licensing

Vical Grants More Options to Merck & Co. for Cancer Targets Abstract pdf
Business Review Editor
NexMed Signs Global Licensing Deal with Novartis Abstract pdf
Business Review Editor

General

Novartis Backs Alnylam and RNAi Abstract
Business Review Editor
ALK-Abello AS Abstract pdf
Business Review Editor

Mergers & Acquisitions

Inyx Increases Capabilities in the Inhaled Drug Market Abstract pdf
Business Review Editor
Covance Acquires Clinical Services Facility from West Pharmaceutical Abstract pdf
Business Review Editor

Business Commentaries

Where Does Innovation Prosper? html
Fintan Walton


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.